… effectiveness of biologic agents working as TNF-α inhibitors (… colchicine in children and
adolescents with symptomatic FMF … colchicine-resistant pediatric patients initiated the etanercept …

… more frequent in the colchicine-resistant group (97% vs 68% in … of CNK for FMF adults,
adolescents and children aged 2 years and … started etanercept (0.8 mg/kg/week). The therapy with …

Familial Mediterranean fever (FMF) is a recessive, autosomal, auto-inflammatory disorder
characterised by brief, recurring, self-limited episodes of fever and serositis resulting in …

… Anakinra and canakinumab are efficient and safe … In this study we aimed to investigate
the efficacy and safety of anti-… Four adolescent female who had FMF attacks only during the …

… in colchicine-resistant FMF (crFMF) patients since the beginning of this century. Citation8
Anakinra, a … effective and safe in patients with colchicine-resistant or colchicine-intolerant FMF. …

… for autoinflammatory syndromes in children and adolescents (AID-NET) … The efficacy of
IL-1-blocking drugs in colchicine-resistant FMF (… While comparative trials between anakinra and …

… and efficacy in preventing familial Mediterranean fever (FMF) attacks among individuals with
colchicine-resistant (… In that study, anakinra was administered during prominent prodrome or …

… study were to assess the efficacy of rilonacept in decreasing … have been used for
colchicine-resistant FMF, including tumor … anakinra, 4 weeks for etanercept, and 8 weeks for …

… colchicine-resistant FMF patients and patients with amyloidosis during childhood and adolescent
… After anakinra or canakinumab therapy, their lives completely changed without any or …

… Anakinra for the treatment of colchicine-resistant FMF has also been reported to be efficacious
… Colchicine use in children and adolescents with familial mediterranean fever: literature …